Skip to main content
. 2020 Jan 21;6:2055207619901085. doi: 10.1177/2055207619901085

Table 6.

Number of substance use projects receiving NIH funding from 2011–2017.

Year/key term 2011n = 5 (%) 2012n = 9 (%) 2013 n = 11 (%) 2014 n = 16 (%) 2015 n = 21 (%) 2016 n = 24 (%) 2017 n = 25 (%) Total unique studies across all years accounting for duplicates n = 50 (%)
Alcohol 2 (40.0) 4 (44.4) 4 (36.4) 12 (75.0) 17 (81.0) 18 (75.0) 14 (56.0) 32 (65)
Smoking/tobacco 4 (80.0) 6 (66.7) 8 (72.7) 10 (62.5) 10 (47.6) 11 (45.8) 14 (56.0) 27 (54)
Marijuana 0 (0.0) 0 (0.0) 0 (0.0) 4 (25.0) 5 (23.8) 5 (20.8) 5 (20.0) 9 (18)
Opioid 0 (0.0) 0 (0.0) 0 (0.0) 2 (12.5) 2 (9.5) 2 (8.3) 0 (0.0) 2 (4)
Cocaine 0 (0.0) 1 (11.1) 1 (9.1) 1 (6.3) 2 (9.5) 2 (8.3) 0 (0.0) 3 (6)
Meth-amphetamine 0 (0.0) 1 (11.1) 1 (9.1) 0 (0.0) 1 (4.8) 1 (4.2) 0 (0.0) 2 (4)
Heroin 0 (0.0) 0 (0.0) 0 (0.0) 1 (6.3) 1 (4.8) 1 (4.2) 0 (0.0) 1 (2)
Ecstasy 0 (0.0) 0 (0.0) 0 (0.0) 1 (6.3) 2 (9.5) 1 (4.2) 0 (0.0) 2 (4)